Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GENB
GENB logo

GENB News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GENB News

Analysts Initiate Coverage on Generate Biomedicines with Strong Upside Potential

7h agoseekingalpha

Key Wall Street Rating Updates from Tuesday

14h agoCNBC

Cathie Wood Continues to Add to Growth Stock Positions

Mar 03 2026Fool

February IPO Market Review and Outlook

Mar 02 2026renaissancecapital

Generate Biomedicines Announces IPO Terms for $400 Million Raise

Feb 27 2026renaissancecapital

Generate Biomedicines Plans $400 Million IPO Amid February Market Lull

Feb 27 2026renaissancecapital

Generate Biomedicines Raises $400 Million in IPO for AI-Driven Therapies

Feb 27 2026renaissancecapital

GENB Events

No data

No data

GENB Monitor News

No data

No data

GENB Earnings Analysis

No Data

No Data

People Also Watch